Recruiting

Observational Study

Sponsor:

Regeneron Pharmaceuticals

Code:

NCT03936335

Conditions

Adverse Pregnancy Outcomes

Atopic Dermatitis

Eligibility Criteria

Sex: Female

Age: 18 - 49

Healthy Volunteers: Not accepted

Interventions

dupilumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-02. This information was provided to ClinicalTrials.gov by Regeneron Pharmaceuticals on 2025-08-03.